Coya Therapeutics (COYA) Treasury Shares (2023 - 2024)
Coya Therapeutics (COYA) reported Treasury Shares of $21500.0 for Q4 2024, up 30.3% on a YoY basis from $16500.0 in Q1 2024, and little changed sequentially from $21500.0 in Q3 2024.
Coya Therapeutics (COYA) Treasury Shares (2023 - 2024) Analysis & Trends
Coya Therapeutics (COYA) has 2 years of Treasury Shares data on file, last reported at $21500.0 in Q4 2024.
- For the quarter ending Q4 2024, Treasury Shares rose 30.3% year-over-year to $21500.0; the trailing twelve-month figure through Dec 2024 stood at $21500.0 (up 30.3% YoY), and the FY2024 full-year result was $21500.0, up 30.3% from the prior year.
- Treasury Shares held at $21500.0 in Q4 2024, from $21500.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $21500.0 in Q2 2024 to a low of $16500.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | 265,401.92 |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 473.74 Bn | 468.95 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.07 Bn | 114.82 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.24 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | - |
| 10 | Coya Therapeutics | 98.05 Mn | 47.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 21,500.00 |
| Dec 31, 2024 | 21,500.00 |
| Sep 30, 2024 | 21,500.00 |
| Sep 30, 2024 | 21,500.00 |
| Jun 30, 2024 | 21,500.00 |
| Jun 30, 2024 | 21,500.00 |
| Dec 31, 2023 | 16,500.00 |
| Dec 31, 2023 | 16,500.00 |
| Sep 30, 2023 | 16,500.00 |
| Sep 30, 2023 | 16,500.00 |
| Jun 30, 2023 | 16,500.00 |
| Jun 30, 2023 | 16,500.00 |
| Mar 31, 2023 | 16,500.00 |
| Mar 31, 2023 | 16,500.00 |